Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report)’s share price traded up 18.1% on Thursday. The stock traded as high as $13.39 and last traded at $13.39. 16,695 shares were traded during mid-day trading, an increase of 105% from the average session volume of 8,145 shares. The stock had previously closed at $11.3374.
Santen Pharmaceutical Stock Performance
The firm has a 50 day simple moving average of $11.13 and a 200-day simple moving average of $11.51.
Santen Pharmaceutical Company Profile
Santen Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company focused on ophthalmology. The company researches, develops, manufactures and markets prescription medicines and other products used to diagnose and treat eye diseases.
Its product portfolio includes ophthalmic treatments for conditions such as glaucoma, dry eye, allergic eye disease, ocular infections and retinal disorders. Santen also develops therapies for other vision-related conditions and provides products for eye-care professionals and patients.
Founded in 1890 and headquartered in Osaka, Japan, Santen serves patients and medical professionals through operations and commercial activities in Japan and international markets, including parts of Asia, Europe and other regions.
Read More
- Five stocks we like better than Santen Pharmaceutical
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
